The new CEO of BATS Global Markets told the Kansas City Business Journal that his company is not planning an IPO now.
The number of Americans filing new claims for unemployment benefits rose and productivity contracted more sharply than previously thought.
A judge has tentatively approved a $415 million settlement in a class action suit employee poaching suit. Re/code reports.
One player has retired at the grand old age of 24, after earning around $773,000 a year playing games.
Learning to walk the walk the hard way, a top marketing exec reveals the mistakes he made when first trying to market his company.
A measure of buying interest, which has called the bottom in three stocks so far this year, is signaling the bottom may be in on Alibaba.
CNBC's Jim Cramer also says the euro will trade at parity with the dollar now that the ECB has rolled out its QE plan.
The pain of all that overstretching during the last housing boom isn't over yet.
Sales of existing homes in Boston were down in January, but those buyers made offers before the big snow hit.
A stronger euro would "probably would weigh on the stock market," says Jim Iuorio, managing director at TJM Institutional Services.
The ECB will commence its monthly 60-billion-euro ($66.3 billion) bond purchases on March 9, bank head Mario Draghi said Thursday.
"I want the public to see my email. I asked State to release them..." Clinton tweeted. NBCNews reports.
Your risk of an audit may be lower this year, but it still makes sense to prepare for questions from the IRS.
A new study found that there are several paths people can take to become millionaires, USA Today reports.
Markets are fully valued, and investors are getting mixed signals, resulting in a pause after the Nasdaq hit 5,000, strategists tell CNBC.
Employers cut fewer jobs in February than in January, but total layoffs remained high compared to a year ago as the energy sector slashed positions.
Much of the South was forecast to see temperatures drop 30 to 45 degrees in a 24-hour period. NBCNews reports.
German carmaker BMW said its talks with technology giant Apple did not involve developing or building a car, denying a German magazine report.
Drugmaker AbbVie said it will buy Pharmacyclics for about $21 billion to boost its oncology drugs pipeline.